In addition, a recent study has demonstrated that the histone methyltransferase SMYD3, which primarily catalyzes H3K4me2/3, was significantly elevated in the prefrontal cortex of AD patients and P301S Tau mice. This evidence concerns the gene MAPT and Alzheimer disease.